SUBSCRIBE
SUBSCRIBE
News   Business

Merck & Co., Inc. to Build $297M Vaccine Plant in Ireland

November 27, 2007 | 
1 min read

DUBLIN, Nov 27 (Reuters) - U.S. drugmaker Merck & Co (MRK.N: Quote, Profile, Research) will build a new 200 million euro ($297 million) plant in Ireland to develop and manufacture human vaccines, officials said on Tuesday.

Real estate Europe
Merck & Co.
MORE ON THIS TOPIC
Sign outside BioNTech's building in Germany
Breast cancer
BioNTech Builds Case for PD-L1/VEGF Bispecific With Promising Breast Cancer Data
December 11, 2024
 · 
2 min read
 · 
Tristan Manalac
Podcast
Highlights From ASH, Lilly and Novo’s Manufacturing Boon, Momentum in Neuro, More
December 11, 2024
 · 
1 min read
 · 
Heather McKenzie
Group Of Employees Being Fired By Their Company.
Layoffs
Carisma Therapeutics to Cut 34% of Staff, Reprioritize Pipeline
December 10, 2024
 · 
2 min read
 · 
Angela Gabriel
Correct decision chosing - confused man character standing on the crossroads and looking at signpost with three different directions - conceptual vector illustration
Depression
Relmada Considering ‘Strategic Alternatives’ After Failure of Depression Asset
December 9, 2024
 · 
1 min read
 · 
Heather McKenzie